Stock 4726 MYCENAX BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Mycenax Biotech Inc.

Equities

4726

TW0004726005

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 30/06/2024 BST 		5-day change 1st Jan Change
61 TWD +3.39% Intraday chart for Mycenax Biotech Inc. -0.97% +70.87%
05-15 Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-14 Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Mycenax Biotech Inc. Announces the Appointment of Li-Ju Yeh as Corporate Governance Officer
CI
Mycenax Biotech Inc. cancelled the transaction announced on March 13, 2023
CI
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd
CI
Mycenax Biotech Inc. Announces Resignation of Stacy Sun as Corporate Governance Officer, Effective on February 29, 2024
CI
Mycenax Biotech Inc. Announces Board Changes
CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Mycenax Biotech Inc. Announces Resignation of Yu-Ching Chang as Financial and Accounting Officer, Effective on August 11, 2023
CI
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Mycenax Biotech Inc. announced a financing transaction
CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Mycenax Biotech Inc. announced that it expects to receive TWD 1.659112761 billion in funding from JCR Pharmaceuticals Co., Ltd., Center Laboratories, Inc.
CI
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4726 Stock
  4. News Mycenax Biotech Inc.